关注
Heval Atas Guvenilir
Heval Atas Guvenilir
其他姓名Heval Atas, Heval Ataş, Heval Ataş Güvenilir
Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)
在 scai.fraunhofer.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases
AS Rifaioglu, H Atas, MJ Martin, R Cetin-Atalay, V Atalay, T Doğan
Briefings in bioinformatics 20 (5), 1878-1912, 2019
4482019
Learning functional properties of proteins with language models
S Unsal, H Atas, M Albayrak, K Turhan, AC Acar, T Doğan
Nature Machine Intelligence 4 (3), 227-245, 2022
1162022
Crowdsourced mapping of unexplored target space of kinase inhibitors
A Cichońska, B Ravikumar, RJ Allaway, F Wan, S Park, O Isayev, S Li, ...
Nature communications 12 (1), 3307, 2021
682021
CROssBAR: comprehensive resource of biomedical relations with knowledge graph representations
T Doğan, H Atas, V Joshi, A Atakan, AS Rifaioglu, E Nalbat, A Nightingale, ...
Nucleic acids research 49 (16), e96-e96, 2021
262021
How to approach machine learning-based prediction of drug/compound–target interactions
H Atas Guvenilir, T Doğan
Journal of Cheminformatics 15 (1), 16, 2023
172023
Anti-cancer effect of clofazimine as a single agent and in combination with cisplatin on U266 multiple myeloma cell line
İZ Durusu, HH Hüsnügil, H Ataş, A Biber, S Gerekçi, EA Güleç, C Özen
Leukemia Research 55, 33-40, 2017
172017
Protein domain-based prediction of drug/compound–target interactions and experimental validation on LIM kinases
T Doğan, E Akhan Güzelcan, M Baumann, A Koyas, H Atas, IR Baxendale, ...
PLoS Computational Biology 17 (11), e1009171, 2021
152021
Martin, MJ—Cetin-Atalay, R.—Atalay, V.—Dogan, T.: Recent Applications of Deep Learning and Machine Intelligence on in silico Drug Discovery: Methods, Tools and Databases
AS Rifaioglu, H Atas
Briefings in Bioinformatics 20 (5), 1878-1912, 2019
92019
Evaluation of methods for protein representation learning: a quantitative analysis
S Unsal, H Ataş, M Albayrak, K Turhan, AC Acar, T Doğan
bioRxiv, 2020.10. 28.359828, 2020
72020
Phylogenetic and other conservation-based approaches to predict protein functional sites
H Atas, N Tuncbag, T Doğan
Computational Drug Discovery and Design, 51-69, 2018
62018
CROssBAR: comprehensive resource of biomedical relations with deep learning applications and knowledge graph representations
T Doğan, H Atas, V Joshi, A Atakan, AS Rifaioglu, E Nalbat, A Nightingale, ...
bioRxiv, 2020.09. 14.296889, 2020
32020
CROssBAR: comprehensive resource of biomedical relations with network representations and deep learning
V Joshi, T Doğan, R Atalay, MJ Martin, R Saidi, H Zellner, V Volynkin, ...
22019
Anti-Cancer Effects of Clofazimine As a Single Agent and in Combination with Cisplatin in Multiple Myeloma
I Durusu, HH Husnugil, H Atas, A Biber, S Gerekci, AE Gulec, C Ozen
Blood, The Journal of the American Society of Hematology 128 (22), 5897-5897, 2016
22016
Target Specific De Novo Design of Drug Candidate Molecules with Graph Transformer-based Generative Adversarial Networks
A Ünlü, E Çevrim, A Sarıgün, H Çelikbilek, HA Güvenilir, A Koyaş, ...
arXiv preprint arXiv:2302.07868, 2023
2023
Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools
R Cetin-Atalay, DC Kahraman, E Nalbat, AS Rifaioglu, A Atakan, ...
Journal of Gastrointestinal Cancer 52 (4), 1266-1276, 2021
2021
Repurposing of antipsychotic agent trifluoperazine for multiple myeloma treatment: in vitro studies
H Ataş
Middle East Technical University, 2016
2016
CROssBAR: Comprehensive Resource of Biomedical Relations with Network Representations and Deep Learning”, Oral presentation
M Atalay, T Doğan, R Atalay, E Nalbat, A Rifaioğlu, H Ataş, M Martin
系统目前无法执行此操作,请稍后再试。
文章 1–17